Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-07-28 | Karen A. Dawes (1)(2)(3) 57 Director (1) Member of the Compensation Committee (2) Member of the Audit Committee (3) Member of the Nominating and Corporate Governance Committee Director Compensation Table 6 Karen A. Dawes 36,750 71,301 108,051 |
| 2010-07-28 | Karen A. Dawes has served as a Director of Repligen since September 2005. ... (1) Member of the Compensation Committee (2) Member of the Audit Committee (3) Member of the Nominating and Corporate Governance Committee ... The following table sets forth a summary of the compensation the Company paid to its non-employee directors in the year ended March 31, 2010. Karen A. Dawes Fees Earned or Paid in Cash($) 46,000 Option Awards($) 59,858 Total($) 105,858 |
| 2011-07-29 | The following table sets forth a summary of the compensation the Company paid to its non-employee directors in the year ended March 31, 2011. Karen A. Dawes Fees Earned or Paid in Cash($): 41,500 Option Awards($): 37,882 Total($): 79,382 |
| 2012-04-20 | The following table sets forth a summary of the compensation the Company paid to its non-employee directors in the nine months ended December 31, 2011. Karen A. Dawes 40,750 25,196 65,946 |
| 2013-04-09 | Karen A. Dawes, Chairperson of the Board effective December 2011 ... has served as a Director of Repligen since September 2005. ... Ms. Dawes serves as the Chairperson of the Nominating and Corporate Governance Committee. ... The Audit Committee currently consists of Mr. Ryan, Ms. Dawes and Mr. Cooper. ... Director Compensation Table for the Fiscal Year Ended December 31, 2012: Karen A. Dawes: Fees Earned or Paid in Cash $103,500, Stock Awards $50,002, Total $153,502. |
| 2014-04-08 | Karen A. Dawes (3) 62 Director, Chairperson of the Board; Member of the Nominating and Corporate Governance Committee; Director Compensation Table for the Fiscal Year Ended December 31, 2013: Karen A. Dawes Fees Earned or Paid in Cash $119,000, Stock Awards $50,001, Total $169,001. |
| 2015-04-17 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. ... Ms. Dawes also serves as a Director of Symbiomix Therapeutics, LLC and Depomed, Inc. ... Ms. Dawes' qualifications to sit on the Company's Board of Directors include her extensive strategic experience in both a managerial and consulting capacity with pharmaceutical companies as well as her considerable commercial background. ... The Nominating and Corporate Governance Committee of the Board of Directors consists currently of Ms. Dawes, Chairperson, Mr. Griffith and Mr. Ryan. ... Ms. Dawes serves as the Chairperson of the Nominating and Corporate Governance Committee. ... Director Compensation Table for the Fiscal Year Ended December 31, 2014 ... Karen A. Dawes 201,000 Fees Earned or Paid in Cash ($) 69,998 Stock Awards ($) 69,915 Option Awards ($) Total 340,913 |
| 2016-04-11 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. ... Ms. Dawes also serves as a Director of Symbiomix Therapeutics, LLC and Depomed, Inc. ... Ms. Dawes' qualifications to sit on the Company's Board of Directors include her extensive strategic experience in both a managerial and consulting capacity with pharmaceutical companies as well as her considerable commercial background. ... The Nominating and Corporate Governance Committee of the Board of Directors consists currently of Ms. Dawes, Chairperson, Mr. Barthelemy and Mr. Ryan. ... Director Compensation Table for the Fiscal Year Ended December 31, 2015 ... Karen A. Dawes Fees Earned or Paid in Cash($) 141,000, Stock Awards($) 61,703, Option Awards($) 65,883, Total($) 268,586. |
| 2017-04-21 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. ... Ms. Dawes also serves as a Director of Symbiomix Therapeutics, LLC and Depomed, Inc. ... The Nominating and Corporate Governance Committee of the Board of Directors consists of Ms. Dawes, Chairperson, Mr. Barthelemy and Mr. Ryan. ... Director Compensation Table for the Fiscal Year Ended December 31, 2016 ... Karen A. Dawes 141,000 598,631 66,041 805,672 |
| 2018-04-20 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. ... Ms. Dawes also serves as a member on the board of directors of Symbiomix Therapeutics, LLC and Depomed Inc. ... Ms. Dawes' qualifications to sit on the Company's Board of Directors include her extensive strategic experience in both a managerial and consulting capacity with pharmaceutical companies as well as her considerable commercial background. |
| 2019-04-18 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. ... Ms. Dawes also serves as a member on the board of directors of Assertio Therapeutics, Inc. and Medicines360. ... Ms. Dawes serves as the Chairperson of the Nominating and Corporate Governance Committee. ... Director Compensation Table for the Fiscal Year Ended December 31, 2018: Karen A. Dawes Total Compensation: $331,509. |
| 2020-04-28 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. Ms. Dawes has been appointed to the Audit Committee effective as of the close of the 2020 Annual Meeting. |
| 2021-04-21 | Karen A. Dawes, Chairperson, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. Ms. Dawes also serves on the board of directors of two publicly traded companies. The Board is led by its Chairperson, Karen Dawes, who is an independent director. |
| 2022-04-11 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. ... Ms. Dawes also serves on the board of directors of two publicly traded companies: Vaccitech plc and Medicenna Therapeutics Corp, one private company, PaxMedica, Inc., and on one not-for-profit company, Medicines 360. ... The Audit Committee currently consists of Mr. Muir, Mr. Ryan and Ms. Eglinton Manner. Ms. Eglinton Manner replaced Ms. Dawes as a member of the Audit Committee in February 2021. Mr. Ryan will not stand for re-election to the Board at the expiration of his current term at the close of the Annual Meeting. Ms. Dawes rejoined the Audit Committee in April 2022 in view of Mr. Ryan's upcoming retirement. ... The N&CG Committee of the Board consists of Ms. Dawes, Mr. Barthelemy and Mr. Ryan. Ms. Dawes serves as the Chairperson of the N&CG Committee. ... Director Compensation Table for the Fiscal Year Ended December 31, 2021 shows total compensation $372,505. |
| 2023-04-11 | Karen A. Dawes, Chairperson President, Knowledgeable Decisions, LLC 71 2005 ✓ 2 CHAIR 176,989 102,505 102,485 381,979 |
| 2024-04-01 | Karen A. Dawes, Chairperson of the Board, has served as a director of Repligen since September 2005. She is currently President of Knowledgeable Decisions, LLC, a management consulting firm. |
| 2025-04-04 | Ms. Dawes received a B.A. and M.A. in English from Simmons College and a M.B.A. from Harvard University Graduate School of Business. |
Data sourced from SEC filings. Last updated: 2025-08-30